Insight Health

What Insight Health does

Insight Health is a German pharmaceutical market intelligence provider founded in 1999 as Pharmaintranet Information AG, headquartered in Waldems-Esch, Germany, and operating as a wholly-owned subsidiary of CompuGroup Medical SE & Co. KGaA since 2022. The company serves pharmaceutical manufacturers, biotechnology firms, statutory and private health insurers (GKV/PKV), health authorities, and medical associations across Germany and Austria with data-driven market analytics spanning Rx, OTC, consumer healthcare, medical devices (CI), oncology, and medical cannabis segments. Its portfolio addresses the full product lifecycle from pre-launch market assessment through launch support, sales force optimization, and post-launch performance tracking, plus adjacent use cases in supply chain monitoring and patent intelligence.

The company's platform is built on a proprietary multi-source data foundation: GKV billing data from pharmacy calculation centers, complete wholesale distribution surveys, a panel of approximately 7,000 pharmacies, representative physician panels of 5,000-6,500 office-based physicians (sourced in part from CompuGroup Medical information systems), and anonymized longitudinal patient data covering approximately 64 million SHI patients (~77% of the nationwide statutory health-insured population). Core products include Galaxy Next Generation (a self-service analytics platform with pivot, mapping, and KPI customization), Patient Insights Analytics (PIA, a modular patient-level analysis suite), Darwin Next Generation (diagnosis-prescription analytics), Pharmacy Cube (pharmacy profiling and environmental analysis), SHARK (an international patent database covering 29 countries), Market Movement Monitor (weekly supply shortage detection), Tender Alert (rebate contract monitoring), Substitutionsmonitor, Klinikspiegel (hospital quality analytics), and specialty offerings for oncology and Medizinalcannabis (Green Line).

Insight Health generates revenue primarily through enterprise subscriptions and project-based consulting engagements sold directly to pharmaceutical and healthcare clients on annual contracts, with pricing customized to client requirements and no publicly disclosed price list. Go-to-market combines direct enterprise sales, content marketing (whitepapers, case studies, market reports), and recurring industry events including the annual Insight Health Roadshow, the Pharma Insights customer conference, and the Online Academy. The company has reported customer satisfaction (CSAT) of 96-97% in consecutive annual customer surveys in 2025 and 2026, and the leadership team comprises Managing Directors Michael Hensoldt (CEO/Chairman), Christian Bensing, and Philipp Thiele.

Name

Insight Health

Legal name

Insight Health GmbH

Website

https://insight-health.de

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

Insight Health is a German pharmaceutical market intelligence provider serving pharma companies, health insurers, and authorities in Germany and Austria with subscription analytics platforms covering prescription, patient, supply chain, and patent data across ~64 million SHI patients.

Ownership category

akta.pro rank

Headquarters

HQ city

Waldems

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Market Intelligence Services: Insight Health generates revenue through providing pharmaceutical market research, prescription data analytics, patient insights, and sales force effectiveness solutions to pharmaceutical companies, biotech firms, health insurers, and healthcare organizations on a subscription and project basis.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Insight Health is a B2B pharmaceutical market intelligence provider that aggregates anonymized healthcare data from pharmacy claims, wholesale distribution, and proprietary physician (~5,000-6,500) and pharmacy (~7,000) panels to deliver prescription analytics, patient journey insights, sales force effectiveness tools, supply chain monitoring, and patent intelligence. Its core offerings are delivered through proprietary platforms such as GalaxyNG, DarwinNG, Patient Insights Analytics (PIA), Pharmacy Cube, Market Movement Monitor, and the SHARK patent database for pharmaceutical companies, biotech firms, health insurers, health authorities, and medical associations in Germany and Austria.

Product overview

Insight Health is a pharmaceutical market intelligence provider offering a platform-plus-modules architecture for the German healthcare market. The core platform includes Galaxy Next Generation for custom data analysis and Patient Insights Analytics (PIA) for modular patient data analysis. These platforms are complemented by specialized solutions including Sales Force Excellence tools (Arzttargeting, Apothekentargeting, Territory Alignment, Zielgruppenmonitoring, Clusteranalysen, Vertriebssteuerung), Real-World Medical Data solutions (DarwinNG, Patient Insights), Supply Chain Analytics (Market Movement Monitor, Substitutionsmonitor, Tender Alert), Spezialtherapeutika (Oncology Insights, Medizinalcannabis/Green Line), Hospital Insights (Klinikspiegel), and specialized data products (Patentdatenbank Shark, Pharmacy Cube, APO Daily/Weekly). The portfolio covers the entire pharmaceutical market research lifecycle from pre-launch through post-launch optimization, serving pharmaceutical companies, health insurers, and health authorities in Germany and Austria.

Differentiator

Problem solved

Functional benefit

Brands

• DarwinNG: Analysis platform for diagnosis and prescription behavior monitoring based on representative physician panels.
• Galaxy Next Generation (Galaxy NG)
• Pharmacy Cube
• Territory Alignment
• Substitutionsmonitor
• Tender Alert
• SHARK
• Market Movement Monitor
• Patient Insights Analytics (PIA)
• Klinikspiegel

Products and services

• Galaxy Next Generation (GalaxyNG) Intuitive analysis platform for pharmaceutical market data enabling custom report building with automatic updates, pivot results, map visualizations, saved analyses, internal query sharing, and custom KPI definitions; for pharmaceutical, biotech, and healthcare clients.
• Patient Insights Analytics (PIA) Modular online solution for analyzing anonymized patient data in Germany with modules for patient and prescription profiles, source of business analyses, comedication analyses, and treatment persistence studies.
• Patentdatenbank SHARK International patent database covering pharmaceutical active ingredients across 29 countries, including approximately 3,500 active ingredients and combinations, nearly 21,000 patents, and more than 31,000 Supplementary Protection Certificates (SPCs).
• Darwin Next Generation (DarwinNG) Interactive database solution providing transparency between physician diagnoses and drug prescriptions, with differentiation by specialist groups and monthly market development views, based on representative panels from 5,000 office-based physicians.
• Pharmacy Cube Online tool providing pharmacy profiles and environmental analyses with current structural data, pharmacy metrics, and characteristics for every pharmacy in Germany, enabling multi-dimensional classification on regional, pharmacy-specific, and socio-demographic levels.
• Market Movement Monitor (MMM) Weekly monitoring solution for tracking medication inventories, sales, and potential supply bottlenecks in OTC and Rx markets with Power BI visualization; used for early detection of supply shortages and out-of-stock situations.
• Tender Alert Monitoring system for health insurance rebate contract tenders providing daily capture of all EU tender announcements with alert functionality.
• Substitutionsmonitor Database combining physician-prescribed PZN with pharmacy-dispensed PZN, providing transparency from prescription to billing, including substitution rates and rebate contract effects.
• Arzttargeting (Physician Targeting) Physician targeting solution enabling efficient sales resource allocation by identifying high-potential prescribers and new prescribers for sales force optimization.
• Apothekentargeting (Pharmacy Targeting) Pharmacy targeting solution identifying high-potential pharmacies for specific markets, enabling sales force briefing and control for pharmacy sales optimization.
• Territory Alignment Data-based structural models for field sales in Rx, OTC, and Care Information segments, developing individualized territory structures balancing potential and workload.
• Zielgruppenmonitoring Instrument for measuring success and efficiency of classical and multi-channel field sales forces, enabling tracking of identified physician groups over time.
• Clusteranalysen Interactive tracking and analysis tool for systematic territory analysis identifying strengths, weaknesses, opportunities, and risks at the micro level.
• Vertriebssteuerung und Prämierung Granular regional data on prescriptions and pharmaceutical wholesale for sales control and compensation excluding prescription migration effects.
• Oncology Insights Data-driven solutions for the German oncology market including national GKV market coverage, preparation of finished medicinal products, and market and competitive observation.
• Medizinalcannabis (Green Line) Pioneer market research offering in medical cannabis since 2017, providing market analyses, consulting services, and tailored workshops for product launches under the Green Line portfolio.
• APO Daily Daily pharmacy data reflecting daily goods movements of public pharmacies, providing insight into the German pharmacy business at PZN level.
• APO Weekly Weekly pharmacy data showing weekly goods movements of public pharmacies to consumers at national and regional levels.
• Klinikspiegel Analysis of German acute hospital quality reports enriched with additional information, showing diagnoses and procedures at department level with case numbers.
• Launchbegleitung (Launch Support) Data-driven market launch support including market analyses, patient insights, physician insights, pharmacy insights, and patent and rebate contracts monitoring across the product lifecycle.

Quantifiable outcome

• 96% customer satisfaction (2026)
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• IQVIA: Global leader in life sciences analytics, RWE, and technology solutions. Overlaps with Insight Health across prescription/patient data analytics and commercial pharma intelligence but operates at much larger scale across multiple geographies, making it a broad incumbent rather than a direct DACH-only competitor.
• Cegedim: European healthcare technology and data company with strong physician panel and real-world data assets in France and other EU markets. Highly comparable to Insight Health in product DNA (physician panels, prescription analytics), but with a broader geographic and product footprint.
• Veeva Systems: Cloud software and data platform for life sciences, including CRM, data, and commercial solutions. Competes with Insight Health in the broader pharma commercial intelligence stack but is broader in scope (CRM, regulatory, clinical) rather than focused on DACH prescription analytics.

Direct peers

• Citeline (formerly Pharma Intelligence/Informa): Provider of drug development and commercial intelligence including trial, pipeline, and prescription/patient analytics. Comparable in offering pharma market intelligence and RWE-style insights, serving similar pharma/biotech customers with subscription data products.
• Evaluate Pharma (Evaluate Ltd): Provider of commercial intelligence and forecasts for the pharma and biotech industry, including drug sales forecasting, patient-based forecasts, and consensus analytics. Directly comparable as a subscription pharma market intelligence vendor serving similar enterprise customers.
• Definitive Healthcare: Provider of commercial intelligence for the healthcare and life sciences industries, including claims data, hospital/physician analytics, and pharma sales targeting. Closely comparable business model to Insight Health's physician/pharmacy targeting and patient analytics offerings.
• Symphony Health (now part of Evidera/PRA): US-focused provider of integrated patient, prescriber, and claims data for pharma commercial analytics. Directly comparable offering to Insight Health's prescription and patient analytics solutions, albeit in a different geographic market.

Emerging players

• AplusA (now part of Evoke): European healthcare market research and consulting firm historically focused on physician and patient research across multiple therapy areas. Comparable to Insight Health in serving pharma market research needs but more reliant on primary survey research than longitudinal prescription/claims data.
• Pharmaspectra: Provider of medical/scientific data analytics built from congress, publication, and KOL engagement data for pharma. Adjacent to Insight Health's prescription/patient analytics and SHARK patent database, with overlap in pharma R&D intelligence use cases.

Others

• DocCheck: German healthcare professional community and marketing/insights platform. Thematically comparable to Insight Health in serving HCP engagement and pharma market research in the DACH market, but operates a different business model (community + media) rather than data panels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/insighthealth
• LinkedInlinkedin.com/company/insight-health-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Insight Health